BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18507431)

  • 21. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
    Klier M; Anastasov N; Hermann A; Meindl T; Angermeier D; Raffeld M; Fend F; Quintanilla-Martinez L
    Leukemia; 2008 Nov; 22(11):2097-105. PubMed ID: 18685613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
    Sun CY; Hu Y; Guo T; Wang HF; Zhang XP; He WJ; Tan H
    Acta Pharmacol Sin; 2006 Nov; 27(11):1447-52. PubMed ID: 17049120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells.
    Madan E; Prasad S; Roy P; George J; Shukla Y
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1232-7. PubMed ID: 18996091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1.
    Shi Y; Yang S; Troup S; Lu X; Callaghan S; Park DS; Xing Y; Yang X
    Oncol Rep; 2011 Jun; 25(6):1713-9. PubMed ID: 21479363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma.
    Lyu MA; Pham LV; Sung B; Tamayo AT; Ahn KS; Hittelman WN; Cheung LH; Marks JW; Cho MJ; Ford RJ; Aggarwal BB; Rosenblum MG
    Biochem Pharmacol; 2012 Aug; 84(4):451-8. PubMed ID: 22687624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.
    Sun Z; Shi S; Li H; Shu XH; Chen XY; Kong QY; Liu J
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):965-73. PubMed ID: 23989725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo.
    Qian Z; Zhang L; Cai Z; Sun L; Wang H; Yi Q; Wang M
    Leuk Res; 2011 Mar; 35(3):380-6. PubMed ID: 21047686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative effect of resveratrol in pancreatic cancer cells.
    Cui J; Sun R; Yu Y; Gou S; Zhao G; Wang C
    Phytother Res; 2010 Nov; 24(11):1637-44. PubMed ID: 21031621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation.
    Kim MY; Trudel LJ; Wogan GN
    Anticancer Res; 2009 Oct; 29(10):3733-40. PubMed ID: 19846903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
    Sareen D; van Ginkel PR; Takach JC; Mohiuddin A; Darjatmoko SR; Albert DM; Polans AS
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3708-16. PubMed ID: 16936077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
    Adhami VM; Afaq F; Ahmad N
    Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bax and Bak are the critical complementary effectors of colorectal cancer cell apoptosis by chemopreventive resveratrol.
    Pöhland T; Wagner S; Mahyar-Roemer M; Roemer K
    Anticancer Drugs; 2006 Apr; 17(4):471-8. PubMed ID: 16550006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.
    Zak Z; Gelebart P; Lai R
    Leukemia; 2010 Aug; 24(8):1476-86. PubMed ID: 20520642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways.
    Shimizu T; Nakazato T; Xian MJ; Sagawa M; Ikeda Y; Kizaki M
    Biochem Pharmacol; 2006 Mar; 71(6):742-50. PubMed ID: 16427027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of Decitabine Combined with Bortezomib on the Proliferation of Mantle Cell Lymphoma Cell Lines and Its Underling Mechanisms].
    Zhang JN; Qiao SK; Chen D; Xing LN; Li Y; Guo XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1197-1204. PubMed ID: 32798398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes.
    Byun HS; Song JK; Kim YR; Piao L; Won M; Park KA; Choi BL; Lee H; Hong JH; Park J; Seok JH; Lee YJ; Kang SW; Hur GM
    Rheumatology (Oxford); 2008 Mar; 47(3):301-8. PubMed ID: 18276737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.
    Ferrer A; Marcé S; Bellosillo B; Villamor N; Bosch F; López-Guillermo A; Espinet B; Solé F; Montserrat E; Campo E; Colomer D
    Oncogene; 2004 Nov; 23(55):8941-9. PubMed ID: 15480431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.